Fondazione Irccs Istituto Nazionale Dei Tumori, Milano

This study looks at whether women with certain aggressive breast cancers (HER2-positive or triple-negative) who have a complete response to chemotherapy can safely avoid surgery or radiation. About 152 women will be monitored closely instead of receiving standard local treatments…

This study is for people with a specific type of advanced colorectal cancer that has spread. It tests a new combination of chemotherapy drugs and a targeted therapy to see if it is safe and works better than current treatments. The goal is to control the cancer and improve surviv…

This study looks at men with a type of prostate cancer that has spread but still responds to hormone therapy. After 6 months of standard drug treatment, some men will also receive either radiation or surgery to the prostate, while others continue with drugs alone. The goal is to …

This study looks at the immune system of people with desmoid tumors, a rare type of growth. Researchers want to find markers in the blood and tumor that can tell if the tumor will shrink, stay the same, or grow. The goal is to better understand the disease and possibly guide futu…

This study looks at a rare cancer of the head and neck called adenoid cystic carcinoma. Researchers want to understand why some people's cancer grows slowly while others' spreads faster. They will study tumor samples and take blood tests from 114 adults with metastatic disease. N…

This study looks at how the natural bacteria in your mouth might influence the success of radiation therapy for head and neck cancer. Researchers will collect saliva samples from 100 patients before, during, and after treatment to see if certain bacteria help control tumors or wo…

This study aims to create a more accurate way to predict duodenal cancer risk in people with familial adenomatous polyposis (FAP), a genetic condition that greatly increases the chance of developing this cancer. Researchers will analyze endoscopy images from 300 participants to b…

This study is for people with a rare cancer called epithelioid haemangioendothelioma (EHE). Researchers will collect medical information and blood samples to look for natural substances (biomarkers) that may help predict how the disease will progress. They will also create lab-gr…

This study is building a large registry of up to 13,600 adults with rare head and neck cancers across Europe. Researchers will collect information from existing databases and doctors to track how these cancers behave, what treatments work best, and how patients fare over time. No…